109 related articles for article (PubMed ID: 27722631)
1. Nanoscale patterning of biopolymers for functional biosurfaces and controlled drug release.
Peer A; Dhakal R; Biswas R; Kim J
Nanoscale; 2016 Nov; 8(44):18654-18664. PubMed ID: 27722631
[TBL] [Abstract][Full Text] [Related]
2. Effects of interfacial layer wettability and thickness on the coating morphology and sirolimus release for drug-eluting stent.
Bedair TM; Yu SJ; Im SG; Park BJ; Joung YK; Han DK
J Colloid Interface Sci; 2015 Dec; 460():189-99. PubMed ID: 26319336
[TBL] [Abstract][Full Text] [Related]
3. Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation.
Koppara T; Joner M; Bayer G; Steigerwald K; Diener T; Wittchow E
Thromb Haemost; 2012 Jun; 107(6):1161-71. PubMed ID: 22535188
[TBL] [Abstract][Full Text] [Related]
4. A Nuclear Magnetic Resonance Spectroscopy as a Method for Evaluation of In Vivo Poly-l-Lactide Biodegradation Kinetics From Stent-Polymer Matrices: An Experimental Study Utilizing Porcine Model of In-Stent Restenosis.
Orlik B; Buszman PP; Krauze A; Gąsior P; Desperak P; Pająk J; Kasperczyk J; Janas A; Jelonek M; Handzlik-Orlik G; Buszman PE; Milewski K
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):93-9. PubMed ID: 25944843
[TBL] [Abstract][Full Text] [Related]
5. Optimized polymer coating for magnesium alloy-based bioresorbable scaffolds for long-lasting drug release and corrosion resistance.
Xu W; Yagoshi K; Koga Y; Sasaki M; Niidome T
Colloids Surf B Biointerfaces; 2018 Mar; 163():100-106. PubMed ID: 29284158
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two biodegradable-polymer-based sirolimus-eluting stents with varying elution and absorption kinetics in patients with acute myocardial infarction: A subgroup analysis of the PANDA III trial.
Guan C; Xu B; Qiao S; Qin L; Li Y; Li Z; Guo Y; Sun Z; Song L; Gao R;
Catheter Cardiovasc Interv; 2017 Mar; 89(S1):520-527. PubMed ID: 28109057
[TBL] [Abstract][Full Text] [Related]
7. Effect of solvent on drug release and a spray-coated matrix of a sirolimus-eluting stent coated with poly(lactic-co-glycolic acid).
Choi J; Jang BN; Park BJ; Joung YK; Han DK
Langmuir; 2014 Aug; 30(33):10098-106. PubMed ID: 25090045
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable Polymer-Based Sirolimus-Eluting Stents With Differing Elution and Absorption Kinetics: The PANDA III Trial.
Xu B; Gao R; Yang Y; Cao X; Qin L; Li Y; Li Z; Li X; Lin H; Guo Y; Ma Y; Wang J; Nie S; Xu L; Cao E; Guan C; Stone GW;
J Am Coll Cardiol; 2016 May; 67(19):2249-2258. PubMed ID: 27173037
[TBL] [Abstract][Full Text] [Related]
9. Effect of vascular scaffold composition on release of sirolimus.
Jelonek K; Jaworska J; Pastusiak M; Sobota M; Włodarczyk J; Karpeta-Jarzabek P; Kaczmarczyk B; Kasperczyk J; Dobrzyński P
Eur J Pharm Biopharm; 2018 Nov; 132():41-49. PubMed ID: 30179737
[TBL] [Abstract][Full Text] [Related]
10. Comparison of dextran-based sirolimus-eluting stents and PLA-based sirolimus-eluting stents in vitro and in vivo.
Lee SY; Bae IH; Park DS; Jang EJ; Shim JW; Lim KS; Park JK; Sim DS; Jeong MH
J Biomed Mater Res A; 2017 Jan; 105(1):301-310. PubMed ID: 27615559
[TBL] [Abstract][Full Text] [Related]
11. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.
Milewski K; Gorycki B; Buszman PP; Jelonek M; Beaudry D; Lapointe JM; Guy LG; Abusamra M; Pająk J; Kinasz W; Wojakowski W; Leclerc G; Gil RJ; Buszman PE
Kardiol Pol; 2012; 70(7):703-11. PubMed ID: 22825946
[TBL] [Abstract][Full Text] [Related]
12. Development of a sirolimus-eluting poly (L-lactide)/poly(4-hydroxybutyrate) absorbable stent for peripheral vascular intervention.
Grabow N; Bünger CM; Kischkel S; Timmermann JH; Reske T; Martin DP; Williams SF; Schareck W; Sternberg K; Schmitz KP
Biomed Tech (Berl); 2013 Oct; 58(5):429-37. PubMed ID: 23898020
[TBL] [Abstract][Full Text] [Related]
13. Eluting characteristics of a platelet glycoprotein receptor antibody using a PLLA-coated stent.
Wang GX; Yin TY; Luo LL; Hou YB; Wang YZ; Ruan CG; Guzman RP; Guidoin R
J Biomater Sci Polym Ed; 2008; 19(3):359-71. PubMed ID: 18325236
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus-eluting biodegradable poly-L-lactide stent for peripheral vascular application: a preliminary study in porcine carotid arteries.
Bünger CM; Grabow N; Sternberg K; Kröger C; Ketner L; Schmitz KP; Kreutzer HJ; Ince H; Nienaber CA; Klar E; Schareck W
J Surg Res; 2007 May; 139(1):77-82. PubMed ID: 17292417
[TBL] [Abstract][Full Text] [Related]
15. Secreted Matrix Metalloproteinase-9 of Proliferating Smooth Muscle Cells as a Trigger for Drug Release from Stent Surface Polymers in Coronary Arteries.
Gliesche DG; Hussner J; Witzigmann D; Porta F; Glatter T; Schmidt A; Huwyler J; Meyer Zu Schwabedissen HE
Mol Pharm; 2016 Jul; 13(7):2290-300. PubMed ID: 27241028
[TBL] [Abstract][Full Text] [Related]
16. Polymer-Free Drug-Eluting Stents: An Overview of Coating Strategies and Comparison with Polymer-Coated Drug-Eluting Stents.
Chen W; Habraken TC; Hennink WE; Kok RJ
Bioconjug Chem; 2015 Jul; 26(7):1277-88. PubMed ID: 26041505
[TBL] [Abstract][Full Text] [Related]
17. The development of novel biodegradable bifurcation stents for the sustainable release of anti-proliferative sirolimus.
Lee CH; Chen CJ; Liu SJ; Hsiao CY; Chen JK
Ann Biomed Eng; 2012 Sep; 40(9):1961-70. PubMed ID: 22451257
[TBL] [Abstract][Full Text] [Related]
18. Controlled release of sirolimus from a multilayered PLGA stent matrix.
Wang X; Venkatraman SS; Boey FY; Loo JS; Tan LP
Biomaterials; 2006 Nov; 27(32):5588-95. PubMed ID: 16879865
[TBL] [Abstract][Full Text] [Related]
19. Serial Assessment of Strut Coverage of Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months After Stent Implantation by Optical Frequency Domain Imaging: The DISCOVERY 1TO3 Study (Evaluation With OFDI of Strut Coverage of Terumo New Drug Eluting Stent With Biodegradable Polymer at 1, 2, and 3 Months).
Chevalier B; Smits PC; Carrié D; Mehilli J; Van Boven AJ; Regar E; Sawaya FJ; Chamié D; Kraaijeveld AO; Hovasse T; Vlachojannis GJ
Circ Cardiovasc Interv; 2017 Dec; 10(12):. PubMed ID: 29246909
[TBL] [Abstract][Full Text] [Related]
20. Liquid chromatography-tandem mass spectrometry method for determination of Sirolimus coated drug eluting nano porous carbon stents.
Rajender G; Narayanan NG
Biomed Chromatogr; 2010 Mar; 24(3):329-34. PubMed ID: 19662626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
